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Background: Sexual dysfunction is a prevalent, long-term complication of breast cancer and its treatment and can
be treated effectively with face-to-face sexual counselling. However, relatively few women actually opt for face-to-face sex
therapy, with many women indicating that it is too confronting. Internet-based interventions might be a less threatening
and more acceptable approach, because of the convenience, accessibility and privacy it provides. Recent studies
have demonstrated the efficacy of internet-based programs for improving sexual functioning in the general population.
The objective of the current study is to investigate the efficacy of an internet-based cognitive behavioral therapy (CBT)
program in alleviating problems with sexuality and intimacy in women who have been treated for breast cancer.
Methods/design: In a multicenter, randomized controlled trial we are evaluating the efficacy of an internet-based CBT
program in reducing problems with sexuality and intimacy in breast cancer survivors. Secondary outcomes include body
image, marital functioning, psychological distress, menopausal symptoms, and health-related quality of life. We will recruit
160 breast cancer survivors (aged 18-65 years) with a formal DSM-IV diagnosis of sexual dysfunction from general and
academic hospitals in the Netherlands. Women are randomized to either an intervention or waiting-list control group.
Self-report questionnaires are completed by the intervention group at baseline (T0), ten weeks after start of therapy (T1),
post-treatment (T2), 3 months post-treatment (T3), and 9 months post-treatment (T4). The control group
completes questionnaires at T0, T1 and T2.
Discussion: There is a need for accessible and effective interventions for the treatment of sexual dysfunctions in breast
cancer survivors. This study will provide evidence about the efficacy of an internet-based approach to delivering a CBT
intervention targeted specifically at these sexual health issues. If proven to be effective, internet-based CBT for problems
with sexuality and intimacy will be a welcome addition to the care offered to breast cancer survivors. Hopefully
this therapy will lower the barrier to seeking help for these problems, resulting in improved quality of life after
breast cancer.
Trial registration: The study is registered at ClinicalTrials.gov (NCT02091765).
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Breast cancer is the most common type of cancer among
women in the Netherlands [1]. Improved breast cancer
screening and treatment have resulted in increased sur-
vival rates [2]. Consequently, more interest and research
has focused on the health-related quality of life (HRQL)
of breast cancer survivors, including issues of sexuality
and intimacy.
The prevalence rates for sexual dysfunctions as a result of
breast cancer treatment vary between 30% and 100% [3-7].
Breast cancer survivors (BCS) experience worse sexual
functioning compared to women without a history of can-
cer [8-10]. Frequently reported problems include decreased
sexual desire (23-64%), decreased sexual arousal or vaginal
lubrication (20-48%), anorgasmia (16-36%) and dyspareunia
(35-38%) [3].
The different components of breast cancer treatment can
all directly or indirectly affect sexual functioning [3]. Previ-
ous studies have shown that women who have received
chemotherapy are at a higher risk of developing sexual dys-
functions than women who have not undergone this treat-
ment [8,11-17], regardless of the type of surgery [14,18].
Chemotherapy can cause premature, abrupt menopause,
leading to reduced sexual desire in some women [19]. It
can also induce vaginal dryness and atrophy, which subse-
quently can affect sexual functioning [6,8,12,13,15,20]. Re-
sults with regard to endocrine treatment are somewhat
mixed, but studies show that tamoxifen and aromatase
inhibitors can lead to sexual problems [21-27]. The evi-
dence pertaining to the effect of surgery on sexual func-
tioning is mixed [28-30], with some studies showing that
women who undergo a mastectomy report more problems
in sexual functioning than women who receive breast
conserving therapy [28,31,32], while other studies have
not found an association between type of surgery and
sexual functioning [18,29]. More consistent is the finding
that mastectomy more often results in compromised body
image than does breast conserving treatment [4,13,28].
Other common complaints after breast cancer treatment
are concerns about sexual attractiveness and femininity, fa-
tigue, anxiety and depression, fear of loss of fertility, and
overall decreased HRQL [3,18,33,34]. Emotional well-being
and the quality of the partner-relationship can also be af-
fected by the distress surrounding diagnosis and treatment
[35-37]. Although the diagnosis and treatment of any type
of cancer can cause problems in sexual functioning [3],
breast cancer raises particular concerns because of the im-
portance of the breast in feminine sexuality and the breast
as a source of erotic pleasure and stimulation [33].
Sexual dysfunctions can be treated effectively with face-
to-face forms of sex therapy [38-41]. Sex therapy typically
comprises a flexible treatment program including a number
of elements that can be tailored to the needs of individuals
and couples. It typically involves behavioral componentsderived from the sex therapy developed by Masters and
Johnson [42], i.e. psycho-education about sexuality and sex-
ual dysfunction, a temporary ban on intercourse, and sen-
sate focus exercises. A ban on intercourse can break the
vicious cycle of fear of sexual intercourse and subsequent
negative experience and disappointment, and offers the op-
portunity for positive experiences by eliminating or redu-
cing performance demand [43]. Sensate focus exercises
form a hierarchically structured exercise program, through
which partners gradually reintroduce the consecutive
phases of sexual contact. The exercises are targeted at be-
coming more comfortable with one’s own body and achiev-
ing sexual intimacy with one’s partner, both physically and
emotionally. Other goals are to discover new approaches to
sexual stimulation, and to encourage communication be-
tween partners about sexual experiences, sexual desires and
sexual boundaries. These behavioral elements of sex ther-
apy are usually combined with cognitive therapy [40,43].
Through cognitive therapy, therapist and client aim to de-
tect and modify the client’s dysfunctional, disturbing cogni-
tions regarding sexuality that arise during exercises. Via the
method of cognitive restructuring, the dysfunctional cogni-
tions are replaced by more functional appraisals. Sex ther-
apy is often delivered in a couple format, but individual
applications and group therapy formats are also described
in the literature [44,45].
The efficacy of different types of face-to-face therapy
for female sexual dysfunction (FSD) has been demon-
strated, including sexual desire and sexual arousal dis-
order [40,46,47], orgasmic disorder [48,49], sexual pain
[50,51], and vaginismus [52,53]. Several modified treatment
programs have been developed and evaluated for breast
cancer survivors [44,54]. Interventions with stronger effects
tend to be couple-focused and include treatment compo-
nents that educate both partners about the woman’s diag-
nosis and treatment, promote couples’ mutual coping and
support processes, and include treatment components that
make use of specific sex therapy techniques addressing sex-
ual and body image concerns [44,54].
Despite the availability of effective treatments for sexual
dysfunctions, there is a significant discrepancy between the
self-reported need for professional sexual health care in
cancer survivors and the actual uptake of care [5,55]. Kedde
et al. [5] reported that only 40% of BCS who felt a need for
care actually consulted a health professional. Hill et al. [55]
reported that, although over 40% of gynaecologic cancer
and breast cancer survivors expressed interest in receiving
professional care, only 7% had ever actually sought such
care.
Although sexual functioning is an important issue,
health care professionals may be reluctant to query breast
cancer patients about sexual problems during medical
consultations, due to time constraints, embarrassment,
lack of knowledge and experience in this area, and/or lack
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also be difficult for patients to initiate discussion about
their sexual difficulties with their health care professional
[58-60]. It has been suggested that when reporting sensi-
tive or potentially stigmatizing information, individuals
may feel more comfortable undergoing assessment and
treatment via the internet [61,62]. This idea is supported
by a survey [de Blok G. Thesis on the outpatient clinic for
sexuality and breast cancer of The Netherlands Cancer
Institute. Unpublished manuscript] that was conducted in
women who attended an informational meeting of a sexu-
ality and breast cancer clinic, but who subsequently did
not follow-up for an appointment for face-to-face counsel-
ling. While some women indicated that they did not con-
sider treatment of their sexual problems to be necessary,
others indicated that they did not wish to undergo such
treatment in a hospital-setting, or that the face-to-face set-
ting of the counselling formed too great a barrier. Many
respondents suggested that internet-based therapy would
be a less threatening and more acceptable approach. The
advantages of internet-based therapy include privacy, con-
venience and accessibility [63-65], all of which may be par-
ticularly attractive in the area of sexual problems.
There is growing evidence that internet-based CBT is an
effective method to treat a range of psychosocial problems
[66-73]. More recently, internet-based CBT programs
for sexual dysfunctions have been developed and tested
[45,65,74-77]. However, most of these online interventions
have focused on male sexual dysfunctions [74,75,77-80].
Early trials have demonstrated the applicability and effect-
iveness of online CBT for FSD in the general population
[76], and of an online intervention for sexual problems in
breast cancer survivors [81]. However, the efficacy of an
internet-based CBT for sexual problems in BCS has not
yet been researched.
In this article, we describe the design of a randomized,
controlled, multicenter trial that evaluates the efficacy of an
internet-based CBT program for sexual dysfunctions in
women who have been treated for breast cancer. We
hypothesize that women in the internet-based CBT group
will report a significantly greater improvement in sexual
functioning and intimacy than women in a waiting-list con-
trol group. Secondarily, we hypothesize that women who
undergo the internet-based CBT will report significantly
less psychological distress and fewer menopausal symp-
toms, and a significantly greater improvement in body
image, marital functioning and HRQL than women in the
control group.
Methods
In this study, patients are randomized to either an interven-
tion group or a waiting-list control group. Women in the
intervention group will undergo an internet-based CBT
aimed at alleviating problems with sexuality and intimacy.The design of the trial and the anticipated flow of partici-
pants are displayed in Figure 1. The trial has been approved
by the Institutional Review Board of The Netherlands
Cancer Institute (under number NL44153.031.13), as well
as by all review boards of the hospitals from which patients
are being recruited (for a list of the participating hospitals,
see the Acknowledgements section). Patient recruitment
and data collection started in September, 2013.
Study sample
The study sample will be composed of 160 women ful-
filling the following inclusion criteria: (1) age 18-65 years
(the upper limit of 65 years is not based on any assump-
tion regarding the salience of sexuality with increasing
age, but on the smaller chance of access to internet in
this age group); (2) a history of histologically confirmed
breast cancer (stages: T1-T4, N0-N1 and M0); (3) a diag-
nosis of breast cancer six months to five years prior to
study entry; (4) completion of breast cancer treatment
(with the exception of endocrine therapy and immuno-
therapy); (5) disease-free at time of study entry; (6) a
basic fluency in the Dutch language (for assessment and
therapy purposes); and (7) a formal diagnosis of sexual
dysfunction according to the criteria of the Diagnostic
and Statistical Manual of Mental Disorders-IV [82] (to
be established by an experienced sexologist during an in-
take interview). Single as well as partnered women can
participate in the study. Sexual orientation is irrelevant
for eligibility.
Exclusion criteria are: (1) no access to internet; (2) ser-
ious cognitive or psychiatric problems (i.e., depression,
alcohol dependency, or psychotic disorders) as deter-
mined on the basis of the Mini International Neuro-
psychiatric Interview [83]; (3) treatment for another type
of cancer (with the exception of cervix carcinoma in situ
and basal cell carcinoma); (4) presence of severe rela-
tionship problems for which the internet-based program
is not appropriate; (5) participation in a concurrent ther-
apy program to alleviate problems with sexuality or in-
timacy; (6) participation in a concurrent CBT program
for other psychological problems; and (7) participation
in another trial investigating problems with sexuality/
intimacy.
Recruitment and randomization
Patients are recruited from 10 community and university
hospitals in the Netherlands and are identified through
the hospital registries by their physician, or by means of
the database of the Netherlands Cancer Registry. Se-
lected patients are sent an invitation letter describing
the study and internet-based therapy, and are asked to
return a response card to indicate if they are interested
in participation. In case of no interest, women are asked
to specify their reason(s) for this on the card. In the
Patients receive invitation letter and response card
Screening by telephone by member of research staff
Intake evaluation by telephone by sexologist
Patients receive baseline questionnaire (T0)







































































Figure 1 Overview of study procedures. *The total duration of study participation is dependent on the duration of the CBT.
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after the first mailing. Women who are not interested in
participation or who do not respond to the reminder are
not contacted again.
Interested women are screened for eligibility twice: first
by a member of the study staff and subsequently by a sex-
ologist. In these interviews, more information about the
study procedures and therapy is given and eligibility criteria
are checked. The sexologist carries out a diagnostic inter-
view to determine final eligibility of the woman, and the
Mini International Neuropsychiatric Interview [83] is com-
pleted. All sexologists involved in the study are female, and
have undergone special training in the application of the
internet-based CBT program.
Eligible women are sent a baseline questionnaire (T0)
and an informed consent form. Study questionnaires can
be completed online or in a paper-and-pencil format. The
baseline questionnaire assesses sociodemographic and med-
ical background variables, and the study outcomes. If the
score of the marital adjustment subscale of the Maudsley
Marital Questionnaire [84] (see ‘Study measures’ section)
exceeds the cut-off score of 35, the eligibility of the partici-
pant is discussed once more with the sexologists to deter-
mine if the nature and severity of the relationship problems
would recommend treating these problems prior to tackling
the sexual dysfunction, thus resulting in exclusion from
study participation.
Consenting women are randomized to either an interven-
tion group (n = 80) or a waiting-list control group (n = 80)
using the minimization technique, with type of surgery
(breast conserving therapy; mastectomy only; mastectomy
with breast reconstructive surgery), current endocrine treat-
ment for breast cancer (yes; no), time since breast cancer
diagnosis (<1 year; 1-3 yrs; 3-5 yrs), and menopausal status
(premenopausal; postmenopausal) as stratification variables.Study arms
Intervention group: internet-based CBT program
Each woman is assigned a sexologist who guides her
through the internet-based CBT program. Contact with the
therapist is web-based, via a secured, password-protected
website. From a total of 10 modules, the sexologist selects
four to five modules that best fit the sexual problems of the
client. The internet-based CBT program was originally de-
veloped for use in the general population at Virenze, a
mental health center located in Utrecht, the Netherlands.
The program was adapted for use specifically for breast
cancer survivors. This involved editing and adding text re-
lated to the physical and psychosexual problems often ex-
perienced by women who have had breast cancer. The
therapists are licensed psychologists and sexologists who
have undergone additional training in issues relating to
breast cancer, and in the use of the internet program.A description of the content of the different program
modules is provided in Table 1. Each module contains
several interventions, each of which comprises the follow-
ing elements: (1) introduction, (2) psycho-education, (3)
“homework” assignments (e.g., registration exercises; dis-
cuss intimacy with partner; sensate focus exercises) and (4)
reporting back to the therapist and receiving feedback on
the homework assignments. The modules can be used in
varying order, leading to a tailored and flexible treatment
program consisting of a maximum of 20 therapy sessions
that are completed within a period of 24 weeks. A mini-
mum of five sessions is considered the lower limit of ses-
sions required in order to expect an effect. The average
time investment for a participant is 90-120 minutes per
week. Women are motivated by the sexologist to involve
their partner in the treatment, but partner involvement is
not mandatory. The time limit within which the therapist
should respond to incoming messages from a client is set at
five working days. Weekly contact between therapist and
client is pursued. After 10 weeks of treatment, a mid-term
evaluation is held to reflect on the progress so far, and to
adjust goals, if necessary, for the remaining part of treat-
ment. The internet-based CBT program is provided at no
cost to the woman.
Waiting-list control group
Participants in the control group are asked to refrain from
undergoing any psychological or medical interventions for
sexual problems during their participation in the study. To
increase the likelihood that women will remain in the study
until they are offered the CBT program, they are provided
with a booklet addressing questions about sexuality and
cancer. Additionally, six weeks after randomization and
upon completion of the second questionnaire, women in
the control group are contacted by telephone to address
any questions or comments that they may have about their
participation in the study, and to reconfirm that they will
be eligible for the internet-based CBT program upon their
completion of the study.
Data collection
Patients
Patients in both study arms complete a battery of self-
report questionnaires at equivalent moments in time
for the first three assessments (T0: baseline; T1:
10 weeks after start of therapy (intervention group) or
13 weeks after randomization (control group); and T2:
post-treatment (intervention group) or 23 weeks after
randomization (control group), see Figure 1). To
achieve an equivalent average assessment time for both
groups, women in the intervention group complete T2
post-treatment, but always between 20 and 24 weeks
after start of therapy. Women who finish the CBT prior
to 20 weeks complete T2 20 weeks after start of
Table 1 Description of therapy modules
Module 1: Put your problem into words In this module the client describes her sexual problems, and learns how sexuality can be
influenced by the treatment of breast cancer. The sexual response curve and female sexual
dysfunctions are elaborated on. Furthermore, information is given about what intimacy is and
how it interplays with sexuality. Women are encouraged to discuss their sexual problems with
their partner.
Module 2: How is my relationship doing? In this module the client explores the level of intimacy in her relationship, becomes aware of
the amount of quality time spent with the partner, and receives psycho-education about sex
and intimacy. The importance of open communication with the partner is discussed, and advice is
given on how to improve communication with regard to intimacy and in particular sex. The couple
evaluates how their relationship and sex life has been influenced by the diagnosis and treatment of
breast cancer.
Module 3: Sex and my body In this module sensate focus therapy is introduced. The first steps of the hierarchically
structured exercise program are completed. An introduction is given with regard to the
influence of thoughts and external stimuli on the experience of sex. Attention is also paid to
possible tension in the pelvic floor and methods to relax this part of the body.
Module 4: Focus my attention In this module the client receives task concentration training in order to learn to focus her
attention on sexual experiences in such a way that it is beneficial to the client.
Module 5: Explore my body In this module sensate focus therapy is elaborated on and the hierarchically structured
exercise program is completed. The client reports on her experiences with the homework
exercise within a cognitive behavioral framework.
Module 6: Discovering my sexual arousal
feelings (version for male partners)
The topics of this module are similar to the female version (see module 7), but are written
from a male perspective.
Module 7: Discovering my sexual arousal
feelings (female version)
In this module psycho-education is provided about the female body and genitals, female sexual
dysfunction, genital stimulation, sexual techniques, and the male body and genitals. Accompanying
exercises are provided for each subject, including, for example, exposure exercises for sexual
pain disorders. Attention is also paid to the importance of and ways to discuss sexual feelings and
preferences with the partner.
Module 8: Change my thoughts In this module the influence of thoughts on feelings and behavior is explained, and the
client’s dysfunctional cognitions with regard to sex and intimacy are identified. Via the method
of cognitive restructuring these cognitions are replaced by more functional, adaptive thoughts.
Module 9: My sexual preferences In this module the client’s sexual development, sexual needs, myths and beliefs about sex are
evaluated. The client is encouraged to talk about her sexual preferences with her partner, and
an action plan for behavior change is created.
Module 10: Relapse prevention In this module the client reflects on her former automatic behavior and possible risk factors for
relapse. A plan of action is generated to use in the event of a relapse.
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complete questionnaires three months post-treatment
(T3) and nine months post-treatment (T4). The control
group is not asked to complete T3 or T4, but rather is
given the opportunity to undergo the intervention following
completion of T2. This was done because it was not
deemed ethically acceptable to withhold the intervention
from women in the control group for the prolonged period
of time that would be required if they were to complete all
follow-up questionnaires (i.e., approximately one year after
study enrollment). To minimize respondent burden, the T4
questionnaire only includes the questionnaires assessing
the primary outcome measures. In every questionnaire,
women in both the intervention group and control group
are asked if they pursued any other activities to reduce their
sexual problems (e.g., use of vaginal lubricant, relaxation
exercises). A reminder is sent to participants who do not
complete and return the questionnaire within one week. If
a woman does not complete the questionnaire in the week
after the reminder, she is contacted by telephone.Partners
Only partners of the women in the intervention group are
asked to complete questionnaires regarding problems with
sexuality and intimacy (male partner: IIEF [85], female part-
ner: FSFI [86]), and relational functioning (PAIR Inventory
[87], MMQ [84]) at the same points in time as the
participants.Study measures
Sociodemographic and clinical data
Sociodemographic data and clinical data are obtained dur-
ing the screening interview and via the baseline question-
naire. Sociodemographic data include age, education,
relational status, living situation and work status. Clinical
data are collected from the medical records and via
self-report, and include date of breast cancer diagnosis,
treatment (type of surgery, chemotherapy, radiotherapy,
endocrine therapy, immunotherapy), medication use
and comorbidity.
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Detailed descriptions of the outcome measures are pro-
vided in Table 2. Briefly, the primary outcome measures in-
clude standardized self-report questionnaires assessing
problems with sexuality and intimacy. These include the
Sexual Activity Questionnaire [88,89], the Female Sexual
Function Index [86,90], the Female Sexual Distress
Scale-Revised [91] and the PAIR Inventory [87]. Sec-
ondary outcome measures include standardized self-
report questionnaires assessing body image (EORTC
QLQ-BR 23 Body image subscale [92]), menopausal
symptoms (FACT-ES ESS-18 [93]), marital functioning
(MMQ [84]), psychological distress (HADS [94,95])
and HRQL (SF-36 [96,97]). The International Index of
Erectile Function [85] is used to assess sexual function-
ing in male partners.
Compliance with the internet-based CBT program
The level of compliance is established via a question that is
posed to the sexologist at the completion of therapy: ‘How
many of the total number of therapy sessions that you con-
sidered to be optimal for this client has the client actually
completed?’. This question is answered on a five-point
scale, ranging from ‘the client has done all of the sessions I
deemed necessary (100%)’ to ‘the client has not/barely done
the sessions I deemed necessary (less than 25%)’. Addition-
ally, the actual number of completed modules and interven-
tions are extracted from the client’s records at the mental
health center where the internet program is housed. Add-
itionally, at completion of therapy, both the client and the
sexologist are asked to indicate the frequency with which
homework assignments were completed on a five-point
scale (always-frequently-occasionally-rarely-never), and to
indicate the reasons for not completing all homework as-
signments, if applicable. Women who do not complete the
internet-based CBT program are asked to indicate their
reason(s) for discontinuation (e.g., therapy was too inten-
sive, online therapy was not suitable, illness). Every effort
will be made to obtain all questionnaires of all participants,
regardless of whether they do or do not complete their
therapy.
Patients’ evaluation of the intervention program
Upon completion of the CBT, women in the interven-
tion group are asked to complete an evaluation ques-
tionnaire about the program. Questions are posed about
their satisfaction with the program, the perceived effi-
cacy of the program in alleviating sexual problems, their
satisfaction with the choice of modules and exercises,
the usability of the program, if they would recommend
the treatment to other women experiencing similar
problems, and if they would suggest any changes to the
program. Women who discontinue the CBT program
are asked the same questions.A subset of women (approximately 15 from the interven-
tion group) will be asked to participate in an evaluation
interview by telephone. This semi-structured interview
covers the same topic areas as addressed by the self-report
evaluation questionnaire, allowing women to provide feed-
back in a more narrative form. Where applicable, women
will also be asked if their partner would be willing to share
his or her experience with the program.
Statistical issues
Power calculation
The SAQ, FSFI, FSDS-R and PAIR Inventory are the pri-
mary outcome measures on which sample size calcula-
tions are based. With a total sample of 130 women (65
per group), and under the assumption of no interaction,
the study will have a 80% power to detect a 0.5 standard
deviation difference (Cohen’s effect size [98]) for the
main effects of the internet-based CBT program, with
the p-value set at 0.05 (two-sided test). A 0.5 standard
deviation difference is considered to be indicative of
clinically meaningful differences in self-reported symp-
tom experience [98].
We will recruit 160 women into the study, to allow for
an attrition rate of approximately 20% (i.e., women who
discontinue participation in the study entirely, including
failure to complete all follow-up questionnaires). Those
women who discontinue the therapy but complete the
follow-up assessments will be included in the intention-
to-treat analysis.
Statistical analysis
First, student’s t-tests or appropriate non-parametric sta-
tistics will be used to evaluate the comparability of the
intervention and control group at baseline in terms of
sociodemographic and clinical characteristics. If, despite
the stratified randomization procedure, the groups are
not comparable on one or more background variables,
those variables will be employed routinely as covariates
in subsequent analyses.
Questionnaire scores will be calculated according to
published scoring algorithms. Between-group differences
over time in mean scores will be tested using multilevel
analysis. Effect sizes will be calculated using standard
statistical procedures. All analyses will, to as great an ex-
tent as possible, be conducted on an intention-to-treat
basis. Per protocol analyses will also be carried out (as a
secondary analysis), comparing women who meet min-
imal compliance levels with the program with the con-
trol group. We will use correlation analyses to examine
the relationship between degree of program adherence,
partner involvement, and program effect. For the ana-
lysis of the secondary outcome measures, appropriate
statistical (p value) adjustments will be made for mul-
tiple testing. The semi-structured interview data will be
Table 2 Study outcome measures and corresponding questionnaires
Variable Questionnaire Details
Primary outcomes
Sexual functioning SAQ [88,89] • Assesses sexual functioning
• 10 items; 4-point Likert scales
• Subscales: pleasure; discomfort; habit
• Subscale scores: pleasure 0-18; discomfort 0-6; habit 0-3; higher score indicates higher levels of
pleasure; lower score indicates lower levels of discomfort; habit is a single item (0 ‘less sexual activity than
usual’ to 3 ‘much more sexual activity than usual’)
• Time frame: past month
• Test retest kappa: 0.50-0.76
FSFI [86,90] • Assesses sexual functioning
• 19 items; 5- and 6-point Likert scales
• Subscales: desire; arousal; lubrication; orgasm; satisfaction; pain
• Total score*: 2-36/Subscale scores*: desire 1.2-6; arousal 0-6; lubrication 0-6; orgasm 0-6; satisfaction
0.8-6; pain 0-6; higher score indicates better sexual functioning
• Time frame: past 4 weeks
• Cronbach’s alpha: >0.82
FSDS-R [91,99] • Assesses distress related to sexual dysfunction
• 13 items; 5-point Likert scale (0 ‘never’ to 4 ‘always’)
• Total score: 0-52; higher score indicates higher level of sexual distress
• Time frame: past 30 days
• Cronbach’s alpha: >0.88
Intimacy PAIR Inventory [87] • 36 items; 5-point Likert scale (0 ‘strongly disagree’ to 4 ‘strongly agree’)
• Subscales: emotional intimacy; social intimacy; sexual intimacy; intellectual intimacy; recreational
intimacy; conventionality
• Subscale score*: 0-96; higher score indicates higher levels of intimacy
• Time frame: ‘how the relationship is now’
• Cronbach’s alpha: 0.70-0.80
Secondary outcomes
Body image QLQ-BR23 Body Image
subscale [92]
• 4 items; 4-point Likert scale (1 ‘not at all’ to 4 ‘very much’)
• Score: 0-100; higher score indicates higher level of functioning
• Time frame: past week
• Cronbach’s alpha: 0.69-0.91
Menopausal
symptoms
FACT-ES ESS-18 [93] • 18 items; 5-point Likert scale (0 ‘not at all’ to 4 ‘very much’)
• Score range: 0-72; higher score indicates fewer menopausal symptoms
• Time frame: past 7 days
• Cronbach’s alpha = 0.79
Marital functioning MMQ [84] • 20 items; 9-point Likert scale (range 0-8)
• Scales: marital adjustment (M); sexual adjustment (S); general life adjustment (GL)
• Scale scores*: S + GL: 0-40; M: 0-80; higher score indicates greater dissatisfaction in the specific
domain
• Time frame: past 2 weeks
• Cronbach’s alpha in normal vs. distressed group: M = 0.88/0.87; S = 0.64/0.82; GL = 0.60/0.68
Psychological distress HADS [94,95] • 14 items; 4-point Likert scale (range 0-3)
• Subscales: depression (HADS-D); anxiety (HADS-A)
• Total score: 0-42/Subscale scores: 0-21; higher score indicates more psychological distress
• Time frame: past week
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• Cronbach’s alpha: HADS-A: 0.68-0.93; HADS-D: 0.67-0.90
Health-related quality
of life
SF-36 [96,97] • 36 items; dichotomous and 3- to 6-point Likert scales
• Subscales: physical functioning; role limitations due to physical health problems; bodily pain;
social functioning; general mental health; role limitations due to emotional problems; vitality;
general health perceptions
• Subscale score*: 0-100; higher score indicates higher levels of functioning/well-being
• Time frame: past week
• Cronbach’s alpha = 0.66-0.93 (mean: 0.84)
Sexual functioning
(male partners)
IIEF [85] • 15 items; 5-/6-point Likert scale (0-5 or 1-5)
• Subscales: erectile function (EF); orgasmic function (OF); sexual desire (SD); intercourse satisfaction
(IS); overall satisfaction (OS)
• Total score: 5-75/Subscale scores: EF 1-30; OF 0-10; SD 2-10; IS 0-15; OS 2-10; higher score indicates a
higher level of functioning in specific domain
• Time frame: past 4 weeks
• Cronbach’s alpha: 0.73-0.99
*The score is calculated based on weighted items.
FACT-ES ESS-18 = Functional Assessment of Cancer Treatment-Endocrine Symptoms, Endocrine Symptom Subscale; FSDS = Female Sexual Distress Scale;
FSFI = Female Sexual Function Index; HADS = Hospital Anxiety and Depression Scale; IIEF = International Index of Erectile Function; MMQ = Maudsley
Marital Questionnaire; PAIR Inventory = Personal Assessment of Intimacy in Relationships Inventory; QLQ-BR23 = EORTC breast cancer-specific quality of
life questionnaire; SAQ = Sexual Activity Questionnaire; SF-36 = 36-Item Short Form Health Survey.
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qualitative information about the women’s experience
with the intervention.
Discussion
A relatively large percentage of breast cancer survivors
experience sexual problems as a consequence of their
disease and its treatment. Studies show that CBT is an
effective treatment method for alleviating sexual dys-
functions in the general population, when provided in a
face-to-face setting. Recently, more attention has been
paid to developing internet-based interventions targeting
sexual functioning. However, research into internet-
based interventions for FSDs is scarce, and even less is
known about the efficacy of internet-based CBT specific-
ally targeted at breast cancer survivors. In the current
trial, we are investigating the efficacy of an internet-based
CBT in reducing problems with sexuality and intimacy,
psychological distress and menopausal symptoms, and in
improving body image, marital functioning and health-
related quality of life of breast cancer survivors.
This trial has several notable strengths, including: (1) the
randomized trial design, (2) the multicenter nature of the
trial, (3) the comparison of the intervention group with a
waiting-list control group, (4) the use of intention-to-treat
analyses, and (5) the long-term follow-up assessments of
outcomes in women in the intervention group.
This trial also has several limitations. First, it would be
valuable to compare the internet-based CBT group not
only with a control group, but also with a face-to-face
CBT group. However, our previous experience in offer-
ing breast cancer survivors the opportunity to participatein face-to-face sexual therapy proved problematic [de
Blok G. Thesis on the outpatient clinic for sexuality and
breast cancer of The Netherlands Cancer Institute. Un-
published manuscript]. Very few women were willing to
take that step, indicating that they found the face-to-face
setting too confronting. Thus, we anticipated that in-
cluding a face-to-face therapy arm in the trial would
result in substantial recruitment problems. Also, we con-
sider it important to first establish the efficacy of the
internet-based CBT program. If the program proves to
be efficacious, a subsequent step could be a comparative
effectiveness study with face-to-face treatment [61]. Sec-
ond, although as one of the conditions for participating
in the trial, women are asked not to participate in any
other programs targeted at their sexual problems, the
possibility exists that some women (particularly in the
control group) may do so. However, we do not expect
any such activities to be as structured, tailored and tar-
geted at sexual problems specifically after breast cancer
treatment as our CBT program. In any case, at each as-
sessment point, women are asked to report any activities
that they may have undertaken to alleviate their sexual
problems. Third, the absence of T3 and T4 follow-up as-
sessments for the control group precludes a longer-term
between-group comparison of study outcomes. As noted
earlier, this decision was based on both ethical and feasi-
bility considerations. We (and the institutional review
board) did not consider it appropriate to withhold ther-
apy for an extended period of time, which would have
been the case if women in the control group were re-
quired to complete all assessment points before having
the opportunity to participate in the internet-based CBT
Hummel et al. BMC Cancer  (2015) 15:321 Page 10 of 12program. We also believed that such a long waiting list
period would have a significant, negative effect on re-
cruitment into the study.
In conclusion, given the high rates of sexual dysfunc-
tion in breast cancer survivors, there is a need for effect-
ive and accessible treatments for these problems. If
proven to be effective, internet-based CBT can be a valu-
able addition to the standard care offered to breast can-
cer survivors. Hopefully, this treatment will lower the
barrier to seeking help, resulting in an improved quality
of life after treatment of breast cancer.
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